Cerapedics is a Broomfield, Colo.-based orthobiologics company.
Here are five observations:
1. Michael Janssen, DO, of Denver-based Spine Education Research Institute, led the research.
2. The trial demonstrated the i-FACTOR bone graft was safe and effective. It met FDA-mandated non-inferiority success criteria in comparison to local autograft in single-level ACDF for cervical radiculopathy.
3. The i-FACTOR bone graft and autograft had high fusion rates in the study and showed improvements in neck disability index.
4. The i-FACTOR bone graft exhibited a 69 percent success rate in all four primary outcomes, while the autograft demonstrated a 57 percent success rate.
5. The researchers concluded the i-FACTOR bone graft is a strong alternative to autograft bone for ACDF procedures.
More articles on spine:
6 key notes on spinal fusion complications & length of stay
Drs. Ralph G. Dacey Jr., Dawn Tartaglione & more: 13 spine surgeons recently receiving honors — Feb. 8, 2016
Society of Neurological Surgeons names Dr. Ralph Dacey president: 4 key notes
